BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kesh K, Gupta VK, Durden B, Garrido V, Mateo-Victoriano B, Lavania SP, Banerjee S. Therapy Resistance, Cancer Stem Cells and ECM in Cancer: The Matrix Reloaded. Cancers (Basel) 2020;12:E3067. [PMID: 33096662 DOI: 10.3390/cancers12103067] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Cha J, Sim W, Yong I, Park J, Shim J, Chang JH, Kang S, Kim P. Assessing Spatial Distribution of Multicellular Self-Assembly Enables the Prediction of Phenotypic Heterogeneity in Glioblastoma. Cancers 2022;14:5910. [DOI: 10.3390/cancers14235910] [Reference Citation Analysis]
2 Urh K, Zidar N, Boštjančič E. Bioinformatics Analysis of RNA-seq Data Reveals Genes Related to Cancer Stem Cells in Colorectal Cancerogenesis. IJMS 2022;23:13252. [DOI: 10.3390/ijms232113252] [Reference Citation Analysis]
3 Galindo-Pumariño C, Collado M, Castillo ME, Barquín J, Romio E, Larriba MJ, Muñoz de Mier GJ, Carrato A, de la Pinta C, Pena C. SNAI1-expressing fibroblasts and derived-extracellular matrix as mediators of drug resistance in colorectal cancer patients. Toxicol Appl Pharmacol 2022;450:116171. [PMID: 35878797 DOI: 10.1016/j.taap.2022.116171] [Reference Citation Analysis]
4 Wang D, Li Y, Ge H, Ghadban T, Reeh M, Güngör C. The Extracellular Matrix: A Key Accomplice of Cancer Stem Cell Migration, Metastasis Formation, and Drug Resistance in PDAC. Cancers 2022;14:3998. [DOI: 10.3390/cancers14163998] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ruiz-martinez A, Gong C, Wang H, Sové RJ, Mi H, Kimko H, Popel AS. Simulations of tumor growth and response to immunotherapy by coupling a spatial agent-based model with a whole-patient quantitative systems pharmacology model. PLoS Comput Biol 2022;18:e1010254. [DOI: 10.1371/journal.pcbi.1010254] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Saw PE, Chen J, Song E. Targeting CAFs to overcome anticancer therapeutic resistance. Trends Cancer 2022:S2405-8033(22)00055-3. [PMID: 35331673 DOI: 10.1016/j.trecan.2022.03.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
7 Romayor I, García-vaquero ML, Márquez J, Arteta B, Barceló R, Benedicto A, Sahgal P. Discoidin Domain Receptor 2 Expression as Worse Prognostic Marker in Invasive Breast Cancer. The Breast Journal 2022;2022:1-14. [DOI: 10.1155/2022/5169405] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Zhao Q, Liu J. P4HA1, a Prognostic Biomarker that Correlates With Immune Infiltrates in Lung Adenocarcinoma and Pan-Cancer. Front Cell Dev Biol 2021;9:754580. [PMID: 34966739 DOI: 10.3389/fcell.2021.754580] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Tang R, Dang M, Zhang X, Tao J, Shi W, Lu W, Yu R, Su X, Tang Y, Teng Z. Disrupting stromal barriers to enhance photothermal-chemo therapy using a halofuginone-loaded Janus mesoporous nanoplatform. J Colloid Interface Sci 2021;610:313-20. [PMID: 34923269 DOI: 10.1016/j.jcis.2021.11.190] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Yang Z, Xue F, Li M, Zhu X, Lu X, Wang C, Xu E, Wang X, Zhang L, Yu H, Ren C, Wang H, Wang Y, Chen J, Guan W, Xia X. Extracellular Matrix Characterization in Gastric Cancer Helps to Predict Prognosis and Chemotherapy Response. Front Oncol 2021;11:753330. [PMID: 34646782 DOI: 10.3389/fonc.2021.753330] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Allavena P, Digifico E, Belgiovine C. Macrophages and cancer stem cells: a malevolent alliance. Mol Med 2021;27:121. [PMID: 34583655 DOI: 10.1186/s10020-021-00383-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
12 Patil K, Khan FB, Akhtar S, Ahmad A, Uddin S. The plasticity of pancreatic cancer stem cells: implications in therapeutic resistance. Cancer Metastasis Rev 2021;40:691-720. [PMID: 34453639 DOI: 10.1007/s10555-021-09979-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
13 Liu Y, Zhou X, Wang X. Targeting the tumor microenvironment in B-cell lymphoma: challenges and opportunities. J Hematol Oncol 2021;14:125. [PMID: 34404434 DOI: 10.1186/s13045-021-01134-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 16.0] [Reference Citation Analysis]
14 Habič A, Novak M, Majc B, Lah Turnšek T, Breznik B. Proteases Regulate Cancer Stem Cell Properties and Remodel Their Microenvironment. J Histochem Cytochem 2021;:221554211035192. [PMID: 34310223 DOI: 10.1369/00221554211035192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Zhao Y, Zheng X, Zheng Y, Chen Y, Fei W, Wang F, Zheng C. Extracellular Matrix: Emerging Roles and Potential Therapeutic Targets for Breast Cancer. Front Oncol 2021;11:650453. [PMID: 33968752 DOI: 10.3389/fonc.2021.650453] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
16 Jing N, Gao WQ, Fang YX. Regulation of Formation, Stemness and Therapeutic Resistance of Cancer Stem Cells. Front Cell Dev Biol 2021;9:641498. [PMID: 33898430 DOI: 10.3389/fcell.2021.641498] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
17 Pinto F, Santos-Ferreira L, Pinto MT, Gomes C, Reis CA. The Extracellular Small Leucine-Rich Proteoglycan Biglycan Is a Key Player in Gastric Cancer Aggressiveness. Cancers (Basel) 2021;13:1330. [PMID: 33809543 DOI: 10.3390/cancers13061330] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
18 Wu P, Gao W, Su M, Nice EC, Zhang W, Lin J, Xie N. Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment. Front Cell Dev Biol 2021;9:641469. [PMID: 33732706 DOI: 10.3389/fcell.2021.641469] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 39.0] [Reference Citation Analysis]
19 Kazi JU. Mechanisms of Anticancer Therapy Resistance: The Role of Cancer Stem Cells. Int J Mol Sci 2020;21:E9006. [PMID: 33260802 DOI: 10.3390/ijms21239006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]